Optimal Embryonic Stage for Transfer in Poor Responders
NCT ID: NCT04485819
Last Updated: 2020-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2019-01-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Synchronizing Blastocyst in Frozen Embryo Transfer
NCT03128970
Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Protocols
NCT05014867
Evaluation of Blastocyst Morphology and Quality in Patients With Embryo Transfer at the Blastocyst Stage
NCT05510557
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
NCT03152643
Sperm DNA Fragmentation Effects on Blastocyst Morphology Grading, Pregnancy Rate and Implantation Rate
NCT04144621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To determine the optimal embryonic stage for transfer in poor responders.
Method:
Patients were divided into day 3 transfer group and day 5 transfer group. All cases had the same stimulation protocol and planning to do fresh embryo transfer. Assessments will be at Day 1, Day 3 and Day 5/6 according to Gardner's criteria 1999. Embryological and clinical data were recorded and then analyzed using SPSS (version 23) statistical software.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cleavage stage transfer
Poor responders who transfer their embryos in cleavage stage on day 3
Cleavage stage transfer
transferring embryos through ICSI procedures for poor responders on cleavage stage of embryonic development.
Blast stage transfer
Poor responders who transfer their embryos on blast stage on day 5/6
Blast stage transfer
transferring embryos through ICSI procedures for poor responders on blast stage of embryonic development.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cleavage stage transfer
transferring embryos through ICSI procedures for poor responders on cleavage stage of embryonic development.
Blast stage transfer
transferring embryos through ICSI procedures for poor responders on blast stage of embryonic development.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* couples whose planning to do fresh transfer
* male partners have normal semen parameters according to WHO 2010.
Exclusion Criteria
* gestational carriers
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ganin Fertility Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manar Hozyen, MSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Amira Hassan, BSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Hanaa Elkhader, BSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Hosam Zaki
Role: STUDY_CHAIR
Ganin Fertility Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ganin fertility center
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MH0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.